Lisa Bengtson, R.N., M.S.N., O.C.N.

Lisa Bengtson, R.N., M.S.N., O.C.N., is the Nurse Consultant for the Lung and Upper Aerodigestive Cancer Research Group (LUARCG) in the Division of Cancer Prevention at the National Cancer Institute. As the LUARCG Nurse Consultant, Lisa is involved in the development and oversight of early phase Lung and Upper Aerodigestive cancer chemoprevention trials. Lisa is also the co-Project Officer for the DCP Consortia Monitoring Contract, serves as the primary Liaison between CP-CTNet and DCP’s Regulatory Contractor and leads the CP-CTNet Equity, Diversity, and Inclusion committee to collaborate with grantees to identify opportunities to improve CP-CTNet clinical trial accrual in these areas. She has over 10 years of oncology research experience in the NCI’s intramural and extramural programs with over 20 years of experience in medical oncology physician practices and community cancer centers and has been an Oncology Certified Nurse for 34 years. Lisa received her Bachelor of Science in Nursing at the Catholic University of America and her Master’s in Nursing Administration from the University of Texas at Arlington. Lisa received the University of Texas Student Award for Outstanding Clinical Performance and the NIH Award of Merit for work on the development of anti-mesothelin immunotoxin therapy for Malignant Mesothelioma.